For NHS, Health Innovation Networks and system partners, the greatest risks, the greatest risks in MedTech lie in compliance failures, stalled scale-up and capital-heavy infrastructure that slows progress.
At OxDevice, part of the Kaleidex Group, we help de-risk these challenges by embedding ISO 13485 systems from the start, providing transparent milestone tracking and flexible cleanroom access.
This approach reduces complexity, accelerates progress and enables innovators and partners move faster from prototype to clinical trial readiness.
What this means for our NHS, innovation and system partners:
- De-Risked Pathways: ISO 13485 compliance from the start.
- Accelerated Progress: Milestones hit on time.
- Scalable Infrastructure: Access cleanroom capacity without heavy investment.
- Portfolio Confidence: Demonstrated real-world execution.
- Collaborative Development: Enable faster translation of innovations into trials.
By enabling faster traction, clear scale-up pathways and stronger compliance, OxDevice increases valuations, accelerates adoption and helps more innovations reach patients sooner.
Arrange a call to explore how OxDevice can support your next MedTech initiative here
